| Business Summary |
| A biopharmaceutical company which is engaged in developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. |
| General Information |
230 Constitution Drive
Menlo Park, CA 94025
|
| www.geron.com |
| Industry : Drugs |
| Sector: Health Care |
| Employees: 159 |
| CEO: Dr. Thomas B. Okarma, Ph |
| Short Interest |
| Current Month (Mil) |
13.65 |
| Previous Month (Mil) |
12.91 |
| Short Interest Ratio (Days) |
8.70 |
| Management Effectiveness |
| Return on Equity |
n.a. |
| Return on Assets |
-36.00 |
| Return on Investments |
-37.00 |
| Profitability |
| Gross Margin |
n.a. |
| EBIT Margin |
n.a. |
| Profit Margin |
0.00 |
Connect with TheStreet